| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |